Predictive Oncology Inc (NASDAQ: POAI) is 86.59% higher on its value in year-to-date trading and has touched a low of $0.55 and a high of $3.06 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The POAI stock was last observed hovering at around $1.60 in the last trading session, with the day’s loss setting it -0.07%.
Currently trading at $1.53, the stock is 24.06% and 12.56% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.0 million and changing -4.38% at the moment leaves the stock 49.11% off its SMA200. POAI registered -41.38% loss for a year compared to 6-month gain of 92.26%. The firm has a 50-day simple moving average (SMA 50) of $1.3593 and a 200-day simple moving average (SMA200) of $1.026105.
The stock witnessed a 7.75% loss in the last 1 month and extending the period to 3 months gives it a 123.03%, and is 39.09% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 22.82% over the week and 10.65% over the month.
Predictive Oncology Inc (POAI) has around 34 employees, a market worth around $11.03M and $1.38M in sales. Profit margin for the company is -1013.00%. Distance from 52-week low is 178.18% and -50.00% from its 52-week high. The company has generated returns on investments over the last 12 months (-380.51%).
The EPS is expected to grow by 40.23% this year
18.0 institutions hold shares in Predictive Oncology Inc (POAI), with institutional investors hold 3.39% of the company’s shares. The shares outstanding are 7.21M, and float is at 7.10M with Short Float at 5.57%. Institutions hold 3.34% of the Float.
The top institutional shareholder in the company is ADVISORNET FINANCIAL, INC with over 95.0 shares valued at $99.0. The investor’s holdings represent 0.0023 of the POAI Shares outstanding.
